MK6-11303-07417
2 vaccinations
2 coded responses
19 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 381 / TN
- Registered
- 2021-08-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-13
Registered in v-safe
-
2021-08-13
Dose 1 — Pfizer-BioNTech
- 2021-08-14
- 2021-08-15
- 2021-08-16
- 2021-08-17
- 2021-08-18
- 2021-08-19
- 2021-08-20
- 2021-08-27
- 2021-09-03
-
2021-09-10
Dose 2 — Pfizer-BioNTech
-
2021-09-10
Survey response — day 28, dose 1MedDRA: Fatigue, Headache — Feeling: GoodFree text: Random headaches and fatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-09-17
- 2021-09-24
- 2021-10-03
- 2021-10-08
- 2021-10-15
- 2021-10-24
- 2021-12-10
-
2022-03-11
Survey response — 6 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: Had covid in decemberMedDRA releases: 2024-11 · check-in free text available
- 2022-09-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-13 | Pfizer-BioNTech | No |
| 2 | 2021-09-10 | Pfizer-BioNTech | No |
Free text
Release 9 — day 28, dose 1
Symptoms: Random headaches and fatigue
Release 11 — 6 months, dose 2
Symptoms: Had covid in december
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release